Jailing of a Pacemaker Lead During Tricuspid Valve-in-Valve Implantation With an Edwards SAPIEN XT Transcatheter Heart Valve

2015 ◽  
Vol 31 (6) ◽  
pp. 819.e9-819.e11 ◽  
Author(s):  
Jean-Michel Paradis ◽  
Mathieu Bernier ◽  
Christine Houde ◽  
Éric Dumont ◽  
Daniel Doyle ◽  
...  
2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Vicki Zeniou ◽  
Shmuel Chen ◽  
Mony Shuvy ◽  
David Luria ◽  
Chaim Lotan ◽  
...  

High precision is necessary during percutaneous transcatheter heart valve implantation. The precision of the implantation has been established by increasing the heart rate (usually to 200 beats per minute) to the point of significantly reduced cardiac output and thus minimizing valve movement. Routinely, this tachycardia is induced by rapid pacing. Here we report a case of failure to pace during valve-in-valve (VIV) Edwards Sapien XT implantation in the tricuspid valve position. Transient cardiac arrest was induced by intravenous adenosine injection enabling accurate valve implantation.


2017 ◽  
Vol 06 (01) ◽  
pp. e29-e31 ◽  
Author(s):  
Daniel Reichart ◽  
Niklas Schofer ◽  
Florian Deuschl ◽  
Andreas Schaefer ◽  
Stefan Blankenberg ◽  
...  

Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.


Author(s):  
Nils Perrin ◽  
Hajo Muller ◽  
Stephane Noble

We present hereby the case of a 75-year-old woman with a degenerated mitral bioprosthesis and severely reduced left ventricular ejection fraction who underwent a successful trans-septal mitral valve-in-valve (TMViV) replacement using a 29mm Edwards Sapien S3 transcatheter heart valve. We also performed a literature review.


2019 ◽  
Vol 14 (13) ◽  
pp. 1378-1385 ◽  
Author(s):  
Sebastien Hascoet ◽  
Robert Dalla Pozza ◽  
Jamie Bentham ◽  
Ronald Giacomo Carere ◽  
Majed Kanaan ◽  
...  

2012 ◽  
Vol 7 (11) ◽  
pp. 1275-1284 ◽  
Author(s):  
Azeem Latib ◽  
Alfonso Ielasi ◽  
Matteo Montorfano ◽  
Francesco Maisano ◽  
Alaide Chieffo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document